Madam Speaker, my hon. colleague did bring up an interesting aspect of this that I, quite frankly, did not think about, and that was the issue of mefloquine and how that could have potentially impacted the issue in Somalia.
The hon. member may know that at veterans affairs committee, as we studied mental health issues among veterans, the issue of mefloquine came up. In fact, just a couple of weeks ago, I believe it was on September 19, there was a rally of mefloquine survivors out here on Parliament Hill. Along with several of my colleagues and NDP colleagues, I went out there, but not one Liberal member went out there to meet the mefloquine survivors.
They are not asking for much. They are asking for the government to investigate this, for outreach, to find out the impact that mefloquine has had on the lives of those veterans who were administered this while serving in Somalia and other theatres of war.
I believe my hon. colleague was out there. I would like to hear her comments on the issue of mefloquine.